OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CASY$821.5858

Caseys General Stores Inc

Food Retail & DistributionVerified

Caseys General Stores Inc has a market capitalization of $30.36 billion and a price-to-book ratio of 10.07, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 0.87, suggesting that its current liabilities exceed its current assets, which could pose a liquidity risk. The company's capital structure is supported by a debt-to-equity ratio of 0.54, indicating a moderate level of leverage. In terms of profitability, the company's return on equity is 2.89%, which is relatively low compared to industry standards, and its return on assets is 1.37%, further indicating that the company is not efficiently utilizing its assets to generate profits. The company's operating margin is 3.52%, and its net profit margin is 2.42%, both of which are below the industry median, suggesting that the company is underperforming in terms of profitability. The company's revenue is concentrated in a single segment, with no significant geographic diversification reported. This concentration could expose the company to higher risks if there are any adverse changes in the market conditions affecting its primary operations. The company's growth trajectory is expected to be modest, with no significant revenue growth projected in the next fiscal year. The company faces several risk factors, including a liquidity risk due to its current ratio being below 1, which indicates that it may struggle to meet its short-term obligations. The risk assessment also highlights a key flag of negative net cash after subtracting total debt, which could lead to financial distress if not managed properly. The company's dilution risk is currently low, but any future capital raising activities could increase this risk. Recent events, such as analyst estimates, suggest a mixed outlook for the company. The mean price target is $735.72, with a median of $752.00, indicating that analysts have a slightly bearish view on the stock. The mean recommendation of 2.16 suggests a cautious approach, with a majority of analysts recommending a hold.

30-day price · CASY(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCaseys General Stores Inc
TickerCASY.O
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Caseys General Stores Inc operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products at its retail locations.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food Retail & Distribution industry, with a confidence level of 0.92.

Caseys General Stores Inc has a market capitalization of $30.36 billion and a price-to-book ratio of 10.07, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 0.87, suggesting that its current liabilities exceed its current assets, which could pose a liquidity risk. The company's capital structure is supported by a debt-to-equity ratio of 0.54, indicating a moderate level of leverage. In terms of profitability, the company's return on equity is 2.89%, which is relatively low compared to industry standards, and its return on assets is 1.37%, further indicating that the company is not efficiently utilizing its assets to generate profits. The company's operating margin is 3.52%, and its net profit margin is 2.42%, both of which are below the industry median, suggesting that the company is underperforming in terms of profitability. The company's revenue is concentrated in a single segment, with no significant geographic diversification reported. This concentration could expose the company to higher risks if there are any adverse changes in the market conditions affecting its primary operations. The company's growth trajectory is expected to be modest, with no significant revenue growth projected in the next fiscal year. The company faces several risk factors, including a liquidity risk due to its current ratio being below 1, which indicates that it may struggle to meet its short-term obligations. The risk assessment also highlights a key flag of negative net cash after subtracting total debt, which could lead to financial distress if not managed properly. The company's dilution risk is currently low, but any future capital raising activities could increase this risk. Recent events, such as analyst estimates, suggest a mixed outlook for the company. The mean price target is $735.72, with a median of $752.00, indicating that analysts have a slightly bearish view on the stock. The mean recommendation of 2.16 suggests a cautious approach, with a majority of analysts recommending a hold.
Key takeaways
  • Caseys General Stores Inc has a high price-to-book ratio, indicating a premium valuation.
  • The company's liquidity position is weak, with a current ratio below 1.
  • The company's profitability metrics are below industry medians, suggesting inefficiencies in asset utilization.
  • The company's revenue is concentrated in a single segment, increasing its exposure to market risks.
  • Analysts have a mixed outlook on the company, with a mean recommendation of 2.16.
  • # RATIONALES
  • margin_outlook_rationale: The company's operating and net profit margins are below industry medians, indicating potential inefficiencies in cost management.
  • rd_outlook_rationale: No significant R&D expenditures were reported, suggesting limited innovation investment.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$3.60B
Gross profit$798.1M
Operating income$126.7M
Net income$87.0M
R&D
SG&A
D&A
SBC
Operating cash flow$893.0M
CapEx-$522.0M
Free cash flow-$32.9M
Total assets$6.35B
Total liabilities$3.33B
Total equity$3.02B
Cash & equivalents$206.5M
Long-term debt$1.64B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$8.71B$454.0M$312.9M$88.9M
FY-3$12.95B$497.7M$339.8M$265.6M
FY-2$15.09B$639.3M$446.7M$227.6M
FY-1$14.86B$709.6M$502.0M$266.8M
FY0$15.94B$796.4M$546.5M$371.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$4.46B$1.93B$336.5M
FY-3$5.51B$2.24B$158.9M
FY-2$5.94B$2.66B$378.9M
FY-1$6.35B$3.02B$206.5M
FY0$8.21B$3.51B$326.7M
PeriodOCFCapExFCFSBC
FY-4$804.1M-$441.3M$88.9M
FY-3$788.7M-$326.5M$265.6M
FY-2$882.0M-$476.6M$227.6M
FY-1$893.0M-$522.0M$266.8M
FY0$1.09B-$506.2M$371.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$3.60B$126.7M$87.0M-$32.9M
FQ-6$4.10B$251.4M$180.2M$157.4M
FQ-5$3.95B$252.3M$180.9M$148.3M
FQ-4$3.90B$137.2M$87.1M$59.5M
FQ-3$3.99B$155.6M$98.3M$6.5M
FQ-2$4.57B$305.3M$215.4M$194.6M
FQ-1$4.51B$298.7M$206.3M$125.5M
FQ0$3.92B$194.8M$130.1M$39.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$6.35B$3.02B$206.5M
FQ-6$6.50B$3.16B$305.0M
FQ-5$7.73B$3.34B$351.7M
FQ-4$8.22B$3.42B$394.8M
FQ-3$8.21B$3.51B$326.7M
FQ-2$8.37B$3.64B$458.1M
FQ-1$8.59B$3.81B$492.0M
FQ0$8.59B$3.85B$465.0M
PeriodOCFCapExFCFSBC
FQ-7$893.0M-$522.0M-$32.9M
FQ-6$281.4M-$100.6M$157.4M
FQ-5$552.1M-$211.2M$148.3M
FQ-4$757.0M-$325.5M$59.5M
FQ-3$1.09B-$506.2M$6.5M
FQ-2$372.4M-$110.0M$194.6M
FQ-1$719.5M-$281.1M$125.5M
FQ0$979.0M-$464.8M$39.2M
Valuation
Market price$821.58
Market cap$30.36B
Enterprise value$31.79B
P/E348.9
Reported non-GAAP P/E
EV/Revenue8.8
EV/Op income251.0
EV/OCF35.6
P/B10.1
P/Tangible book10.1
Tangible book$3.02B
Net cash-$1.43B
Current ratio0.9
Debt/Equity0.5
ROA1.4%
ROE2.9%
Cash conversion10.3%
CapEx/Revenue-14.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricCASYActivity
Op margin3.5%3.1% medp25 1.2% · p75 6.8%above median
Net margin2.4%2.0% medp25 0.7% · p75 4.1%above median
Gross margin22.2%26.1% medp25 17.2% · p75 32.0%below median
CapEx / revenue-14.5%-2.5% medp25 -4.6% · p75 -1.4%bottom quartile
Debt / equity54.0%56.0% medp25 16.8% · p75 121.1%below median
Observations
IR observations
Mean price target735.72 USD
Median price target752.00 USD
High price target860.00 USD
Low price target580.00 USD
Mean recommendation2.16 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count6.00
Hold count8.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate18.07 USD
Last actual EPS14.64 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 08:08 UTC#38c59a9b
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 14:36 UTCJob: 7f3c42b0